Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Technology appraisal guidance
Reference number: TA223
Published: 25 May 2011

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: comments on the Appraisal Consultation Document received through the NICE website

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: comments on the Appraisal Consultation Document received through the NICE website

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: comments on the Appraisal Consultation Document received through the NICE website
14 April 2011
(29.75 Kb 8 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 April 2011